United States Federal Circuit
BIOGEN, INC. v. BERLEX LABS., INC., 01-1058/59
In claims on patents relating to recombinant DNA technology and the production of human interferon, on the district court's correct claim construction, summary judgment that there is not literal infringement is affirmed.
Appellate Information
- Decided 01/31/2003
- Published 01/31/2003
Judges
Court
- United States Federal Circuit